期刊文献+

泰安市综合性医院感染现患率调查研究 被引量:1

Prevalence rate of nosocomial infection in a general hospital in Taian
下载PDF
导出
摘要 目的为了解院医院感染现患率。方法本研究采取床旁调查和查阅住院病历相结合的方法,对2007年5月17日的住院患者进行医院感染现患率调查。结果共调查住院患者856人,医院感染现患率为7.71%,例次感染现患率为8.53%;现患率较高的科室分别为儿科新生儿组50.00%、综合重症监护室(ICU)44.44%、普外科17.39%、其他外科14.29%、神经内科13.79%;感染部位依次为:下呼吸道、腹腔内组织、泌尿道、表浅切口、胃肠道;当日抗菌药物使用率为59.46%;治疗用药病原体送检率为33.71%。结论该院医院感染现患率较高的科室为儿科新生儿组与综合ICU,需重点监控;抗菌药物使用率较高,病原学送检率较低,需加强对合理使用抗菌药物的管理。 Objective:To investigate the prevalence rate of nosocomial infection(NI) in a hospital.Methods: the method bed-side examination and medical records checking were used to investigate the prevalence rate of NI in the inpatients on May 17,2007.Results: Eight hundred and fifty-six inpatients were investigated,the prevalence rate was 7.71%,case prevalence rate was 8.53%;departments with high prevalence rate were as follows: neonate group of pediatric department(50.00%),general ICU(44.44%),general surgical department(17.39%),other surgical departments(14.29%) and department of neurology(13.79%);infection sites in turn were: lower respiratory tract,tissue in abdominal cavity,urinary tract,superficial incisions,gastrointestinal tract.The usage rate of antimicrobial agents of that day was 59.46%;33.71% of inpatients who received treatment usage of antimicrobial agents were delivered samples for pathogenic detection.Conclusion:It is conclude that departments with higher prevalence rate in the hospital are neonate group of pediatric department and general ICU,these departments should be given stress surveillance.The uage rate of antimicrobial agents is high and the rate of delivering samples is low,the use of antimicrobial agents should be strengthened.
作者 赵爱华
出处 《泰山医学院学报》 CAS 2010年第6期429-431,共3页 Journal of Taishan Medical College
关键词 医院感染 现患率 抗菌药物 nosocomial infection prevalence rate data collection
  • 相关文献

参考文献9

二级参考文献42

  • 1李家泰,张烨,陈亦芳,郝凤兰,陈扬.E test for studying in vitro activity of seven antimicrobial agents against penicillin-susceptible and penicillin-resistant pneumococci[J].Chinese Medical Journal,2000(7):52-55. 被引量:3
  • 2National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing[M]. Ninth informational supplement. NCCLS, 1999. 32-36.
  • 3Abudu L, Blair I, Fraise A, et al. Methicillin-resistant Staphylococcus aureus (MRSA): a community-based prevalence survey. Epidemiol Infect,2001 ,126:351-356.
  • 4Pan A, Catenazzi P, Ferrari L. Evaluation of the efficacy of a program to control nosocomial spread of methicillin-resistant Staphylococcus aureus. Infez Med , 2001 ,9 :163-169.
  • 5Daschner F, Schumpelick V. Schiedel L. MRSA as a challenge to clinical organization. Chirurg ,2002 ,73:924-929.
  • 6Bartley J . First case of VRSA identified in Michigan. Infect Control hospi Epidemiol ,2002,23:480.
  • 7Bergogne-Berezin E. Guideline on antimicrobial chemotherapy for prevention and treatment of infections in the ICU. J Chemother, 2001,1: 134-149.
  • 8Goossens H. MYSTIC program: summary of European data from 1997 to 2000. Diagn Microbiol Infect Dis, 2001, 41: 183-189.
  • 9Leblebicioglu H, Gunaydin M, Esen S, et al. Surveillance of antimicrobial resistance in gram-negative isolates from ICU in Turkey:analysis of data from the last 5 years. J Chemother, 2002, 14:140-146.
  • 10Karlowsky JA, Kelly LJ, Thornsberry C , et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000:TRUST and TSN data for the United States. J Autimicrob Agents , 2002,19: 21-31.

共引文献1889

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部